Early metformin may curb insulin starts in gestational diabetes, while a separate analysis ties a history of the condition to advanced CKM syndrome.
|Articles|January 28, 2022
Daily OTC Pearl: Cystex for Urinary Tract Infection
Author(s)Saro Arakelians, PharmD
Cystex provides prophylaxis for urinary tract infections.
Advertisement
OTC/Lifestyle Pearl of the Day: Cystex
Indication: Cystex is used for urinary tract infection (UTI) prophylaxis.
Insight:
- Dosage: 162 mg/162.5 mg/32 mg
- Dosing: 2 tablets PO q12hr
- Administer with meals and at bedtime.
- Use only after eradication of UTI by other appropriate antibiotic.
- Ingredients:
- Methenamine: Indicated for prophylaxis/suppression for chronic recurring UTIs when long-term therapy is required.
- Sodium salicylate: Analgesic.
- Benzoic acid: Elicits weak antifungal and antibacterial properties; also helps acidify urine.
- Adverse events: Dysuria, gastric upset, nausea, and rash.
- Warning: Methenamine is excreted in human milk; caution advised, risk to infant cannot be ruled out.
- Mechanism of action:
- Methenamine: Hydrolyzed in acidic urine to ammonia and formaldehyde, which are bactericidal agents. Does not convert to formaldehyde in serum.
- Sodium salicylate: Analgesic
- Benzoic acid: Elicits weak antifungal and antibacterial properties; also helps acidify urine.
Sources:
Advertisement
Related to this article
Post hoc AHA 2026 data show the oral GLP-1 receptor agonist lowered systolic blood pressure across hypertension stages, partly beyond weight loss.
Cody Parsons, APh, PharmD, BCCCP, says protected pharmacist access lets patients with heart failure be seen more often than typical clinic visits allow.
The evidence for GLP-1 receptor agonists keeps growing, while access for low-income patients keeps narrowing.
Specialty pharmacists can help patients with cancer weigh the benefits and risks of GLP-1 receptor agonists as use expands and new evidence emerges.
Pharmacists can work alongside dermatologists, nurses, and other health care professionals to help answer skin care–related questions and help patients understand trial outcomes.
Pharmacy Times previews enlicitide, survodutide, diet and heart failure risk, and pharmacist-led HF care ahead of the AHA Scientific Sessions in Chicago.
Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Understanding Kratom: Pharmacology, Safety, and Regulation
2
How Stanford Pharmacists Help Close Heart Failure Therapy Gaps
3
Orforglipron Lowers Systolic BP in ATTAIN-1, ATTAIN-2 Analyses
4
GLP-1s and Obesity Care: Cardiorenal Outcomes, Prescribing Considerations, and Access Barriers
5